(Q49905502)

English

Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.

scientific article published on 18 November 2017

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29151133

Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group. (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29151133

Martin Bornhäuser

14

object named as

Martin Bornhäuser

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

13

object named as

Ulrich Germing

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29151133

Uwe Platzbecker

4

object named as

Uwe Platzbecker

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29151133

Kathrin Nachtkamp

9

object named as

Kathrin Nachtkamp

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

5

object named as

Gesine Bug

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29151133

15

object named as

Guido Kobbe

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29151133

12

object named as

Rainer Haas

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29151133

Mustafa Kondakci

10

object named as

Mustafa Kondakci

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29151133

author name string

Thomas Schroeder

1

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29151133

Christina Rautenberg

2

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29151133

William Krüger

3

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29151133

Juliane Steinmann

6

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29151133

Stefan Klein

7

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29151133

Olaf Hopfer

8

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29151133

Stefanie Geyh

11

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29151133

publication date

18 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29151133

Annals of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29151133

97

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29151133

2

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29151133

335-342

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29151133

Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: part III. Prevention and treatment of relapse after allogeneic transpl

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantatio

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

Successful treatment of relapsed AML after allogeneic stem cell transplantation with azacitidine.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions--a retrospective multicenter analysis from the German Cooperative Transplant Study Gro

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

Factors Determining Responses to Azacitidine in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Early Post-Transplantation Relapse: A Prospective Trial

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

Decitabine in patients with relapsed acute myeloid leukemia (AML) after allogeneic stem cell transplantation (allo-SCT).

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

Low dose decitabine in very high risk relapsed or refractory acute myeloid leukaemia in children and young adults

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

Revised international prognostic scoring system for myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

5-azacytidine as salvage treatment in relapsed myeloid tumors after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

Efficacy of a 3-day, low-dose treatment with 5-azacytidine followed by donor lymphocyte infusions in older patients with acute myeloid leukemia or chronic myelomonocytic leukemia relapsed after allografting

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a center for international blood and marrow transplant research study

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

Lack of objective response of myelodysplastic syndromes and acute myeloid leukemia to decitabine after failure of azacitidine

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

Outcome of patients with high risk Myelodysplastic Syndrome (MDS) and advanced Chronic Myelomonocytic Leukemia (CMML) treated with decitabine after azacitidine failure.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

Genomic Classification and Prognosis in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

Mutational analysis in serial marrow samples during azacitidine treatment in patients with post-transplant relapse of acute myeloid leukemia or myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

Hypomethylating agents after allogeneic blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00277-017-3185-5

21 January 2018

Identifiers

10.1007/S00277-017-3185-5

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29151133

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29151133

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49905502&oldid=1857470624"